You are here

China Inc on buying spree of global healthcare assets

Surge driven by firms seeking to diversify, with slowing local growth, govt push to upgrade 'Made in China' brand

chinapharma.jpg
China's healthcare companies are on an acquisition tear, attempting to buy their way into international markets like never before.

Beijing

CHINA'S healthcare companies are on an acquisition tear, attempting to buy their way into international markets like never before.

Chinese firms have announced more than US$3.9 billion in overseas acquisitions in the pharmaceutical, biotechnology and healthcare sectors this

sentifi.com

Market voices on:

Powered by GET.comGetCom